Meet Your ETF AI Analyst
- Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
- Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.
An announcement from Shanghai Pharmaceuticals Holding Co ( (HK:2607) ) is now available.
Shanghai Pharmaceuticals Holding Co., Ltd. has announced an Extraordinary General Meeting (EGM) scheduled for March 13, 2025, to discuss and approve amendments to the company’s Articles of Association and the election of an independent director for its board. This meeting is pivotal for the company as it considers significant governance changes, potentially impacting its decision-making processes and future strategic direction.
More about Shanghai Pharmaceuticals Holding Co
Shanghai Pharmaceuticals Holding Co., Ltd. is a major player in the pharmaceutical industry in China, focusing on the development, manufacturing, and distribution of medicines and healthcare products. The company is known for its comprehensive range of pharmaceutical services and products, catering to both domestic and international markets.
YTD Price Performance: -26.99%
Average Trading Volume: 10,496
Technical Sentiment Consensus Rating: Buy
Current Market Cap: $8.08B
Learn more about 2607 stock on TipRanks’ Stock Analysis page.